SEARCH

SEARCH BY CITATION

References

  • 1
    Rehak M, Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost 2010; 8: 188694.
  • 2
    McIntosh RL, Mohamed Q, Saw SM, Wong TY. Interventions for branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2007; 114: 83554.
  • 3
    Mohamed Q, McIntosh RL, Saw SM, Wong TY. Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2007; 114: 50724.
  • 4
    Squizzato A, Manfredi E, Bozzato S, Dentali F, Ageno W. Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action. Thromb Haemost 2010; 103: 2716.
  • 5
    Ageno W, Cattaneo R, Manfredi E, Chelazzi P, Venco L, Ghirarduzzi A, Cimino L, Filippucci E, Ricci AL, Romanelli D, Incorvaia C, D’Angelo S, Campana F, Molfino F, Scannapieco G, Rubbi F, Imberti D. Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study. Thromb Res 2010; 125: 13741.
  • 6
    Farahvash MS, Farahvash MM, Moradimogadam M, Mohammadzadeh S. Long-term effect of dalteparin in the prevention of neovascularization of iris in recent-onset central retinal vein occlusion. Arch Iran Med 2008; 11: 53943.
  • 7
    Farahvash MS, Moradimogadam M, Farahvash MM, Mohammadzadeh S, Mirshahi A. Dalteparin versus aspirin in recent-onset branch retinal vein occlusion: a randomized clinical trial. Arch Iran Med 2008; 11: 41822.
  • 8
    Lazo-Langner A, Hawell J, Ageno W, Kovacs MJ. Low molecular weight heparin for the treatment of retinal vein occlusion: a systematic review and meta-analysis of randomized trials. Haematologica 2010; 95: 158793.